Hepatitis C is an infection that causes inflammation in your liver. It's caused by a virus called Hepatitis C virus. You can get it from sharing needles or through blood transfusions before they were screened. Sometimes, the exact source isn't known.
Every report comes from a Lived member, sent anonymously.
Have you tried Sovaldi (Sofosbuvir) for Hepatitis C?
Hepatitis C is an infection of the liver caused by the hepatitis C virus (HCV), which spreads through contact with infected blood. The virus keeps the liver inflamed, and over years that inflammation can leave scar tissue. Heavy scarring, called cirrhosis, can lead to liver failure and liver cancer. The infection has two phases. Acute hepatitis C covers the first months after the virus enters the body. Some people clear it on their own, but more than half go on to chronic hepatitis C, an infection that lasts unless it is treated. Most people with hepatitis C have no symptoms, often for decades, so many learn they have it only from a blood test. Today a short course of antiviral pills cures the large majority of infections, which is why finding it matters.
Hepatitis C spreads when blood carrying the virus gets into another person's bloodstream. In the United States, sharing needles, syringes or other drug injection equipment is the most common route. The virus can also pass through a needlestick injury at work, tattoos or piercings done with unsterile tools or ink, shared razors, toothbrushes or nail clippers, and from a mother to her baby during birth. Spread through sex is possible but uncommon; the chance is higher for men who have sex with men and for people who have HIV, another sexually transmitted infection or multiple partners. Other groups with higher rates include people who received a blood transfusion or organ transplant before 1992 (when routine screening of the US blood supply began), people with hemophilia treated with clotting factor before 1987, people who have been on kidney dialysis, and people born in countries where hepatitis C is common. The virus does not spread through coughing, sneezing, hugging, holding hands, or sharing food, drinks or utensils, and it does not pass through breast milk. Once someone is infected, alcohol and coinfection with hepatitis B or HIV can speed up liver damage.
Because hepatitis C rarely causes symptoms, testing is how most people find out. The Centers for Disease Control and Prevention (CDC) recommends a hepatitis C test at least once for every adult 18 and older, a test during each pregnancy, and repeat testing for as long as someone's risk continues, such as ongoing injection drug use. Anyone who asks for a test should get one. Diagnosis usually takes two steps, often run on the same blood sample. An antibody test shows whether the immune system has ever encountered the virus. A positive antibody result can mean a current infection or one that cleared in the past, so a second test looks for the virus's own genetic material (an HCV RNA test, which also measures the viral load, or amount of virus). Detectable RNA confirms a current infection. Antibodies are expected to stay positive after the virus is gone, so someone who was cured or cleared it needs an RNA test if checked again. Before treatment, clinicians estimate how much scarring the liver has, because that shapes the treatment plan and later follow-up. This is usually done with blood tests and sometimes elastography, an ultrasound-based measurement of liver stiffness in which a stiffer liver means more scarring. A liver biopsy is needed only when other tests leave the answer unclear. Testing for hepatitis B and HIV is part of the same workup.
Treatment is recommended for nearly everyone with hepatitis C, including people who feel well and have little liver damage. The medicines are direct-acting antivirals, pills that block proteins the virus needs to copy itself. Most people take them once a day for 8 to 12 weeks, and more than 95% are cured. Two widely used combinations work against every strain (genotype) of the virus: glecaprevir with pibrentasvir (Mavyret), taken with food for 8 weeks, and sofosbuvir with velpatasvir (Epclusa), taken for 12 weeks. Side effects are usually mild, most often headache and tiredness. Both are approved for children 3 and older as well as adults. Cure means a blood test finds no virus 12 or more weeks after the last dose, which clinicians call a sustained virologic response. Curing hepatitis C sharply lowers the risk of liver failure, liver cancer and liver-related death. A few things shape the plan. Hepatitis B can flare during or after hepatitis C treatment, sometimes seriously, so everyone is tested for hepatitis B first and people who have it are monitored or treated for it as well. A review of every prescription, over-the-counter medicine and supplement checks for interactions. People who take diabetes medicine or warfarin (a blood thinner) need closer checks during treatment, because blood sugar and clotting can shift as the virus clears. Cirrhosis, earlier treatment that did not work, pregnancy, liver cancer or a past liver transplant call for an individualized plan, often with a liver specialist. The medicines are expensive, but most insurance plans provide coverage, and assistance programs exist for people who need help paying.
Without treatment, chronic hepatitis C usually damages the liver slowly, often over decades, and many people feel nothing until scarring is advanced. Treatment changes that course for most people. Treatment itself fits into ordinary life: a daily pill, often with few or no lab visits along the way for people without cirrhosis, and a blood test about 12 weeks after finishing to confirm cure. Taking every dose as prescribed gives the best chance of success. People without cirrhosis who are cured need no special liver follow-up afterward. People with cirrhosis still need a liver ultrasound every 6 months to look for liver cancer, because their risk stays elevated after cure, and they may need other checks of their liver health. Cure does not bring immunity. There is no vaccine, and a person can be infected again, so people with ongoing risk are offered yearly testing and help with prevention, such as not sharing injection equipment. Avoiding alcohol protects the liver, and doctors usually recommend vaccines against hepatitis A and B, which could add further damage. Until cure is confirmed, people can protect others by not sharing razors, toothbrushes or injection equipment, covering cuts, and not donating blood, semen or tissue.
Ask for a hepatitis C test if you have never had one as an adult, are pregnant, or have an ongoing risk. If you may have been exposed, for example through a needlestick or shared injection equipment, see a clinician soon; follow-up testing over the next several months can detect a new infection early. After a positive result, arrange treatment rather than waiting for symptoms. Contact your care team if you notice signs of liver trouble, such as yellowing of the skin or eyes, itching, or swelling of the ankles. People with cirrhosis need emergency care right away for vomiting blood, rectal bleeding, new or worsening confusion or a change in alertness, or swelling of the abdomen that is new or quickly getting worse.
Last reviewed • Oct 2026
Educational content, not medical advice.
The doctors i was going to gave me transportation to everywhere for test then when the last test came up they wouldn't help me n said I have to find my own way there n pay for the test n I have no insurance and don't understand why they would do that to me n give me false hope
i have hepatitis c i am not sure how long i have had this but i believe i got it when i was using iv needle drugs when i was younger. i feel like it makes me tired. i am always tired. do you think that the hep c is doing that to my body.